Alterations of sorbin and SH3 domain containing 3 (SORBS3) in human skeletal muscle following Roux-en-Y gastric bypass surgery
Authors:
- Samantha E. DaySDSamantha E. Day
- Luis A. GarciaLGLuis A. Garcia
- Richard L. ColettaRCRichard L. Coletta
- Latoya E. CampbellLCLatoya E. Campbell
- Tonya R. BenjaminTBTonya R. Benjamin
- Elena A. De FilippisEFElena A. De Filippis
- James A. MaduraJMJames A. Madura
- Lawrence J. MandarinoLMLawrence J. Mandarino
- Lori R. RoustLRLori R. Roust
- Dawn K. ColettaDawn K. Coletta
Open Access
- 2 September 2017
- journal article
- research article
- Published by Springer Nature in Clinical Epigenetics
- Vol. 9 (1) , 1-8
Abstract
Obesity is a disease that is caused by genetic and environmental factors. However, epigenetic mechanisms of obesity are less well known. DNA methylation provides a mechanism whereby environmental factors can influence gene transcription. The aim of our study was to investigate skeletal muscle DNA methylation of sorbin and SH3 domain containing 3 (SORBS3) with weight loss induced by Roux-en-Y gastric bypass (RYGB). Previously, we had shown increased methylation (5.0 to 24.4%) and decreased gene expression (fold change − 1.9) of SORBS3 with obesity (BMI > 30 kg/m2) compared to lean controls. In the present study, basal muscle biopsies were obtained from seven morbidly obese (BMI > 40 kg/m2) female subjects pre- and 3 months post-RYGB surgery, in combination with euglycemic-hyperinsulinemic clamps to assess insulin sensitivity. We identified 30 significantly altered promoter and untranslated region methylation sites in SORBS3 using reduced representation bisulfite sequencing (RRBS). Twenty-nine of these sites were decreased (− 5.6 to − 24.2%) post-RYGB compared to pre-RYGB. We confirmed the methylation in 2 (Chr.8:22,423,690 and Chr.8:22,423,702) of the 29 decreased SORBS3 sites using pyrosequencing. This decreased methylation was associated with an increase in SORBS3 gene expression (fold change + 1.7) post-surgery. In addition, we demonstrated that SORBS3 promoter methylation in vitro significantly alters reporter gene expression (P < 0.0001). Two of the SORBS3 methylation sites (Chr.8:22,423,111 and Chr.8:22,423,205) were strongly correlated with fasting plasma glucose levels (r = 0.9, P = 0.00009 and r = 0.8, P = 0.0010). Changes in SORBS3 gene expression post-surgery were correlated with obesity measures and fasting insulin levels (r = 0.5 to 0.8; P < 0.05). These results demonstrate that SORBS3 methylation and gene expression are altered in obesity and restored to normal levels through weight loss induced by RYGB surgery.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK094013)
This publication has 20 references indexed in Scilit:
- Identification of Novel Changes in Human Skeletal Muscle Proteome After Roux-en-Y Gastric Bypass SurgeryDiabetes, 2016
- Metabolic Mechanisms in Obesity and Type 2 Diabetes: Insights from Bariatric/Metabolic SurgeryObesity Facts, 2015
- MethylSig: a whole genome DNA methylation analysis pipelineBioinformatics, 2014
- Early Enhancements of Hepatic and Later of Peripheral Insulin Sensitivity Combined With Increased Postprandial Insulin Secretion Contribute to Improved Glycemic Control After Roux-en-Y Gastric BypassDiabetes, 2014
- Mechanism of Metabolic Advantages After Bariatric SurgeryDiabetes Care, 2013
- Weight Loss after Gastric Bypass Surgery in Human Obesity Remodels Promoter MethylationCell Reports, 2013
- Morbid obesity rates continue to rise rapidly in the United StatesInternational Journal of Obesity, 2012
- Mitochondrial dysfunction and insulin resistance from the outside in: extracellular matrix, the cytoskeleton, and mitochondriaAmerican Journal of Physiology-Endocrinology and Metabolism, 2011
- Proteomics Analysis of Human Skeletal Muscle Reveals Novel Abnormalities in Obesity and Type 2 DiabetesDiabetes, 2009
- PROMO: detection of known transcription regulatory elements using species-tailored searchesBioinformatics, 2002